TherapeuticsMD | TXMD - Pre Utilidad Fiscal





Pre Utilidad Fiscal Cambio Fecha
AbbVie USD 5.57B 2.9B 2026-03
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Cipla INR 7.49B 4.2B 2026-03
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Novo Nordisk DKK 25.52B 8.29B 2025-09
Pfizer USD 5.18B 6.82B 2026-03
TherapeuticsMD USD -1.05M 241K 2024-06